hVIVO (HVO) Competitors

Ergomed (LON:ERGO) and hVIVO (LON:HVO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation, earnings and community ranking.

Which has more risk & volatility, ERGO or HVO?

Ergomed has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, hVIVO has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500.

Which has better earnings & valuation, ERGO or HVO?

hVIVO has lower revenue, but higher earnings than Ergomed. hVIVO is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ergomed	£152.09M	4.61	£15M	£0.29	4,641.38
hVIVO	£58.67M	3.45	£16.11M	£0.02	1,487.50

Does the MarketBeat Community believe in ERGO or HVO?

Ergomed received 119 more outperform votes than hVIVO when rated by MarketBeat users. Likewise, 75.63% of users gave Ergomed an outperform vote while only 69.89% of users gave hVIVO an outperform vote.

Company	Underperform	Outperform
Ergomed	Outperform Votes 242 75.63%	Underperform Votes 78 24.38%
hVIVO	Outperform Votes 123 69.89%	Underperform Votes 53 30.11%

Does the media prefer ERGO or HVO?

In the previous week, hVIVO had 3 more articles in the media than Ergomed. MarketBeat recorded 3 mentions for hVIVO and 0 mentions for Ergomed. hVIVO's average media sentiment score of 0.23 beat Ergomed's score of -0.08 indicating that Ergomed is being referred to more favorably in the media.

Company	Overall Sentiment
Ergomed	Neutral
hVIVO	Neutral

Do analysts rate ERGO or HVO?

Ergomed presently has a consensus target price of GBX 1,350, suggesting a potential upside of 0.30%. Given hVIVO's higher probable upside, equities research analysts plainly believe Ergomed is more favorable than hVIVO.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ergomed	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
hVIVO	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Is ERGO or HVO more profitable?

hVIVO has a net margin of 27.47% compared to hVIVO's net margin of 9.87%. Ergomed's return on equity of 59.09% beat hVIVO's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ergomed	9.87%	18.08%	10.16%
hVIVO	27.47%	59.09%	9.58%

Do institutionals & insiders hold more shares of ERGO or HVO?

71.1% of Ergomed shares are owned by institutional investors. Comparatively, 14.2% of hVIVO shares are owned by institutional investors. 18.2% of Ergomed shares are owned by company insiders. Comparatively, 39.2% of hVIVO shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Ergomed beats hVIVO on 10 of the 16 factors compared between the two stocks.